-
公开(公告)号：US20110166132A1
公开(公告)日：2011-07-07
申请号：US12746902
申请日：2008-12-12
申请人： Stephen A. Hitchcock , Jian J. Chen , Mqhele Vellah Ncube , Thomas Nixey , Albert Amegadzie , Roxanne Kunz , Wenyan Qian , Ning Chen , Christopher M. Tegley , Frenel F. De Morin , Chester Chenguang Yuan , Qingyian Liu , Jiawang Zhu , Tanya A.N. Peterkin , Jeffrey A. Adams , Essa Hu , Frank Chavez, JR.
发明人： Stephen A. Hitchcock , Jian J. Chen , Mqhele Vellah Ncube , Thomas Nixey , Albert Amegadzie , Roxanne Kunz , Wenyan Qian , Ning Chen , Christopher M. Tegley , Frenel F. De Morin , Chester Chenguang Yuan , Qingyian Liu , Jiawang Zhu , Tanya A.N. Peterkin , Jeffrey A. Adams , Essa Hu , Frank Chavez, JR.
IPC分类号： A61K31/538 , C07D213/56 , C07D413/12 , C07D401/12 , C07D401/14 , C07D413/14 , C07D405/12 , C07D233/61 , C07D403/12 , A61K31/4418 , A61K31/4439 , A61K31/496 , A61K31/444 , A61K31/4725 , A61K31/4545 , A61K31/5377 , A61K31/4433 , A61K31/4709 , A61K31/4164 , A61K31/4178 , A61P25/28
CPC分类号： C07D213/40 , C07D401/12 , C07D401/14 , C07D405/12 , C07D413/12
摘要： The present invention provides compounds that are gamma secretase modulators and are therefore useful for the treatment of diseases treatable by modulation of gamma secretase such as Alzheimer's disease. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
摘要翻译： 本发明提供了γ-分泌酶调节剂的化合物，因此可用于治疗通过调节γ分泌酶如阿尔茨海默病可治疗的疾病。 还提供含有这些化合物的药物组合物和制备这些化合物的方法。
-
2.发明授权公开(公告)号：US08440674B2
公开(公告)日：2013-05-14
申请号：US13163666
申请日：2011-06-17
申请人： Frenel F. De Morin , Jian J. Chen , Elizabeth M. Doherty , Stephen A. Hitchcock , Qi Huang , Joseph L. Kim , Gang Liu , Thomas Nixey , Nick A. Paras , Jeffrey Petkus , Daniel Martin Retz , Adrian Leonard Smith , Jiawang Zhu
发明人： Frenel F. De Morin , Jian J. Chen , Elizabeth M. Doherty , Stephen A. Hitchcock , Qi Huang , Joseph L. Kim , Gang Liu , Thomas Nixey , Nick A. Paras , Jeffrey Petkus , Daniel Martin Retz , Adrian Leonard Smith , Jiawang Zhu
IPC分类号： A01N43/54
CPC分类号： C07D401/14 , C07D239/84 , C07D239/95 , C07D401/04 , C07D403/04 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04
摘要： The present invention comprises a new class of compounds capable of modulating Raf kinase and, accordingly, useful for treatment of Raf kinase mediated diseases, including melanomas, tumors and other cancer-related conditions. The compounds have a general Formula I wherein R1 is and A1, A2, A3, A4, X, Z, Z′, R1, R2, R3, R4, R5 and R6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of Raf kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.
摘要翻译： 本发明包括能够调节Raf激酶的新一类化合物，因此可用于治疗Raf激酶介导的疾病，包括黑素瘤，肿瘤和其它癌症相关病症。 该化合物具有通式I，其中R1为和A1，A2，A3，A4，X，Z，Z'，R1，R2，R3，R4，R5和R6如本文所定义。 本发明还包括药物组合物，用于治疗Raf激酶介导的疾病的方法，以及可用于制备本发明化合物的中间体和方法。
-
公开(公告)号：US20110251199A1
公开(公告)日：2011-10-13
申请号：US13163666
申请日：2011-06-17
申请人： Frenel F. De Morin , Jian J. Chen , Elizabeth M. Doherty , Stephen Hitchcock , Qi Huang , Joseph L. Kim , Gang Liu , Thomas Nixey , Nick A. Paras , Jeffrey Petkus , Daniel M. Retz , Adrian L. Smith , Jiawang Zhu
发明人： Frenel F. De Morin , Jian J. Chen , Elizabeth M. Doherty , Stephen Hitchcock , Qi Huang , Joseph L. Kim , Gang Liu , Thomas Nixey , Nick A. Paras , Jeffrey Petkus , Daniel M. Retz , Adrian L. Smith , Jiawang Zhu
IPC分类号： A61K31/502 , A61K31/517 , A61P35/00 , A61K31/506 , C07D403/10 , C07D413/14 , C07D417/10 , C07D401/14
CPC分类号： C07D401/14 , C07D239/84 , C07D239/95 , C07D401/04 , C07D403/04 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04
摘要： The present invention comprises a new class of compounds capable of modulating Raf kinase and, accordingly, useful for treatment of Raf kinase mediated diseases, including melanomas, tumors and other cancer-related conditions. The compounds have a general Formula I and A1, A2, A3, A4, X, Z, Z′, R1, R2, R3, R4, R5 and R6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of Raf kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.
摘要翻译： 本发明包括能够调节Raf激酶的新一类化合物，因此可用于治疗Raf激酶介导的疾病，包括黑素瘤，肿瘤和其它癌症相关病症。 该化合物具有通式Ⅰ和A1，A2，A3，A4，X，Z，Z'，R1，R2，R3，R4，R5和R6的定义。 本发明还包括药物组合物，用于治疗Raf激酶介导的疾病的方法，以及可用于制备本发明化合物的中间体和方法。
-
4.发明授权Amino heteroaryl compounds as beta-secretase modulators and methods of use 有权氨基杂芳基化合物作为β-分泌酶调节剂和使用方法公开(公告)号：US08735384B2
公开(公告)日：2014-05-27
申请号：US13522823
申请日：2011-01-14
申请人： Nick A. Paras , James Brown , Yuan Cheng , Stephen A. Hitchcock , Ted Judd , Patricia Lopez , Ana Elena Minatti , Thomas Nixey , Timothy Powers , Christopher M. Tegley , Qiufen Xue , Bryant Yang , Wenge Zhong
发明人： Nick A. Paras , James Brown , Yuan Cheng , Stephen A. Hitchcock , Ted Judd , Patricia Lopez , Ana Elena Minatti , Thomas Nixey , Timothy Powers , Christopher M. Tegley , Qiufen Xue , Bryant Yang , Wenge Zhong
IPC分类号： A61K31/535 , A01N57/00 , A61K31/675
CPC分类号： C07D401/10 , C07D215/38 , C07D403/10 , C07D405/04 , C07D405/10 , C07D405/12 , C07D413/10 , C07D471/04 , C07D471/08 , C07D498/08
摘要： The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula (I); wherein ring A, B1, B2, B3, L, R1, R2, ring Z, m and n of Formula I are defined herein. The invention also includes use of these compounds in pharmaceutical compositions for treatment, prophylactic or therapeutic, of disorders and conditions related to the activity of beta-secretase protein. Such disorders include, for example, Alzheimer's Disease (AD), cognitive deficits, cognitive impairment, schizophrenia and other central nervous system conditions related to and/or caused by the formation and/or deposition of plaque on the brain. The invention also comprises further embodiments of Formula (I), intermediates and processes useful for the preparation of compounds of Formula (I).
摘要翻译： 本发明包括可用于调节β-分泌酶酶活性和用于治疗β-分泌酶介导的疾病（包括阿尔茨海默病（AD））和相关病症的新一类化合物。 在一个实施方案中，化合物具有通式（I）; 其中式I中的环A，B1，B2，B3，L，R1，R2，环Z，m和n定义在本文中。 本发明还包括在药物组合物中用于治疗，预防或治疗与β-分泌酶蛋白活性相关的病症和病症的用途。 这些疾病包括例如阿尔茨海默氏病（AD），认知缺陷，认知障碍，精神分裂症和与脑上形成和/或沉积斑块相关和/或引起的其他中枢神经系统病症。 本发明还包括式（I）的其它实施方案，可用于制备式（I）化合物的中间体和方法。
-
公开(公告)号：US20070265256A1
公开(公告)日：2007-11-15
申请号：US11708866
申请日：2007-02-20
申请人： Mark Arrington , Ruiping Liu , Allen Hopper , Richard Conticello , Truc Nguyen , Carla Gauss , Roland Burli , Stephen Hitchcock , Essa Hu , Roxanne Kunz , Thomas Nixey , Shannon Rumfelt , Nign Chen
发明人： Mark Arrington , Ruiping Liu , Allen Hopper , Richard Conticello , Truc Nguyen , Carla Gauss , Roland Burli , Stephen Hitchcock , Essa Hu , Roxanne Kunz , Thomas Nixey , Shannon Rumfelt , Nign Chen
IPC分类号： A61K31/535 , A61K31/50 , A61P25/18 , C07D237/26 , C07D413/00
CPC分类号： C07D237/28 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/10 , C07D405/10 , C07D405/14 , C07D409/10 , C07D409/14 , C07D413/04 , C07D413/10 , C07D413/14 , C07D417/04 , C07D417/10 , C07D417/14 , C07D471/04 , C07D487/04 , C07D513/04
摘要： The present invention is directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and process for preparing such compounds. This invention is also directed to methods of treating diseases treatable by inhibition of PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
摘要翻译： 本发明涉及某些作为PDE10抑制剂的噌啉化合物，含有这些化合物的药物组合物及其制备方法。 本发明还涉及通过抑制PDE10酶如肥胖症，非胰岛素依赖型糖尿病，精神分裂症，双相情感障碍，强迫症等治疗疾病的方法。
-
6.发明申请Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use 有权氨基杂芳基化合物作为β-分泌酶调节剂和使用方法公开(公告)号：US20130040931A1
公开(公告)日：2013-02-14
申请号：US13522823
申请日：2011-01-14
申请人： Nick A. Paras , James Brown , Yuan Cheng , Stephen A. Hitchcock , Ted Judd , Patricia Lopez , Ana Elena Minatti , Thomas Nixey , Timothy Powers , Christopher M. Tegley , Qiufen Xue , Bryant Yang , Wenge Zhong
发明人： Nick A. Paras , James Brown , Yuan Cheng , Stephen A. Hitchcock , Ted Judd , Patricia Lopez , Ana Elena Minatti , Thomas Nixey , Timothy Powers , Christopher M. Tegley , Qiufen Xue , Bryant Yang , Wenge Zhong
IPC分类号： A61K31/5377 , C07D413/04 , C07D471/04 , A61P25/16 , A61K31/4709 , C07D417/14 , A61P25/28 , A61P25/00 , C07D413/14 , C07D405/14
CPC分类号： C07D401/10 , C07D215/38 , C07D403/10 , C07D405/04 , C07D405/10 , C07D405/12 , C07D413/10 , C07D471/04 , C07D471/08 , C07D498/08
摘要： The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula (I); wherein ring A, B1, B2, B3, L, R1, R2, ring Z, m and n of Formula I are defined herein. The invention also includes use of these compounds in pharmaceutical compositions for treatment, prophylactic or therapeutic, of disorders and conditions related to the activity of beta-secretase protein. Such disorders include, for example, Alzheimer's Disease (AD), cognitive deficits, cognitive impairment, schizophrenia and other central nervous system conditions related to and/or caused by the formation and/or deposition of plaque on the brain. The invention also comprises further embodiments of Formula (I), intermediates and processes useful for the preparation of compounds of Formula (I).
摘要翻译： 本发明包括可用于调节β-分泌酶酶活性和用于治疗β-分泌酶介导的疾病（包括阿尔茨海默病（AD））和相关病症的新一类化合物。 在一个实施方案中，化合物具有通式（I）; 其中式I中的环A，B1，B2，B3，L，R1，R2，环Z，m和n定义在本文中。 本发明还包括在药物组合物中用于治疗，预防或治疗与β-分泌酶蛋白活性相关的病症和病症的用途。 这些疾病包括例如阿尔茨海默氏病（AD），认知缺陷，认知障碍，精神分裂症和与脑上形成和/或沉积斑块相关和/或引起的其他中枢神经系统病症。 本发明还包括式（I）的其它实施方案，可用于制备式（I）化合物的中间体和方法。
-
公开(公告)号：US07332511B2
公开(公告)日：2008-02-19
申请号：US11195159
申请日：2005-08-01
申请人： Elizabeth M. Doherty , Jiawang Zhu , Markian Stec , Mark H. Norman , Hui-Ling Wang , Christopher H. Fotsch , Ning Chen , Partha P. Chakrabarti , Celia Dominguez , James Richard Falsey , Christopher Hulme , Jodie Katon , Thomas Nixey , Vassil I. Ognyanov , Liping H. Pettus , Robert Michael Rzasa
发明人： Elizabeth M. Doherty , Jiawang Zhu , Markian Stec , Mark H. Norman , Hui-Ling Wang , Christopher H. Fotsch , Ning Chen , Partha P. Chakrabarti , Celia Dominguez , James Richard Falsey , Christopher Hulme , Jodie Katon , Thomas Nixey , Vassil I. Ognyanov , Liping H. Pettus , Robert Michael Rzasa
IPC分类号： C07D213/30 , C07D213/32 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , A61K31/4427 , A61P19/02 , A61P35/00
CPC分类号： C07D231/40 , C07D209/08 , C07D209/12 , C07D209/42 , C07D209/48 , C07D213/26 , C07D213/643 , C07D213/74 , C07D213/75 , C07D215/227 , C07D215/38 , C07D217/04 , C07D231/56 , C07D233/38 , C07D239/42 , C07D239/90 , C07D241/42 , C07D263/56 , C07D265/36 , C07D277/62 , C07D277/82 , C07D307/79 , C07D319/20 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/14 , C07D413/12 , C07D417/12
摘要： Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
-
公开(公告)号：US20050277631A1
公开(公告)日：2005-12-15
申请号：US11195134
申请日：2005-08-01
申请人： Elizabeth Doherty , Jiawang Zhu , Markian Stec , Mark Norman , Hui-Ling Wang , Christopher Fotsch , Ning Chen , Partha Chakrabarti , Celia Dominguez , James Falsey , Christopher Hulme , Jodie Katon , Thomas Nixey , Vassil Ognyanov , Liping Pettus , Robert Rzasa
发明人： Elizabeth Doherty , Jiawang Zhu , Markian Stec , Mark Norman , Hui-Ling Wang , Christopher Fotsch , Ning Chen , Partha Chakrabarti , Celia Dominguez , James Falsey , Christopher Hulme , Jodie Katon , Thomas Nixey , Vassil Ognyanov , Liping Pettus , Robert Rzasa
IPC分类号： A61P29/00 , C07D209/08 , C07D209/12 , C07D209/42 , C07D209/48 , C07D213/26 , C07D213/64 , C07D213/643 , C07D213/74 , C07D213/75 , C07D215/22 , C07D215/227 , C07D215/38 , C07D217/04 , C07D231/40 , C07D231/56 , C07D233/38 , C07D239/42 , C07D239/90 , C07D241/42 , C07D263/56 , C07D265/36 , C07D277/62 , C07D277/82 , C07D307/79 , C07D319/20 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/14 , C07D413/12 , C07D417/12 , A61K31/549 , A61K31/501 , C07D417/02 , C07D43/02
CPC分类号： C07D231/40 , C07D209/08 , C07D209/12 , C07D209/42 , C07D209/48 , C07D213/26 , C07D213/643 , C07D213/74 , C07D213/75 , C07D215/227 , C07D215/38 , C07D217/04 , C07D231/56 , C07D233/38 , C07D239/42 , C07D239/90 , C07D241/42 , C07D263/56 , C07D265/36 , C07D277/62 , C07D277/82 , C07D307/79 , C07D319/20 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/14 , C07D413/12 , C07D417/12
摘要： Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
-
公开(公告)号：US07148221B2
公开(公告)日：2006-12-12
申请号：US11195134
申请日：2005-08-01
申请人： Elizabeth M. Doherty , Jiawang Zhu , Markian Stec , Mark H. Norman , Hui-Ling Wang , Christopher H. Fotsch , Ning Chen , Partha P. Chakrabarti , Celia Dominguez , James Richard Falsey , Christopher Hulme , Jodie Katon , Thomas Nixey , Vassil I. Ognyanov , Liping H. Pettus , Robert Michael Rzasa
发明人： Elizabeth M. Doherty , Jiawang Zhu , Markian Stec , Mark H. Norman , Hui-Ling Wang , Christopher H. Fotsch , Ning Chen , Partha P. Chakrabarti , Celia Dominguez , James Richard Falsey , Christopher Hulme , Jodie Katon , Thomas Nixey , Vassil I. Ognyanov , Liping H. Pettus , Robert Michael Rzasa
IPC分类号： C07D237/14 , C07D237/18 , C07D223/16 , C07D223/18 , A61K31/501 , A61P25/06
CPC分类号： C07D231/40 , C07D209/08 , C07D209/12 , C07D209/42 , C07D209/48 , C07D213/26 , C07D213/643 , C07D213/74 , C07D213/75 , C07D215/227 , C07D215/38 , C07D217/04 , C07D231/56 , C07D233/38 , C07D239/42 , C07D239/90 , C07D241/42 , C07D263/56 , C07D265/36 , C07D277/62 , C07D277/82 , C07D307/79 , C07D319/20 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/14 , C07D413/12 , C07D417/12
摘要： Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
-
公开(公告)号：US07144888B2
公开(公告)日：2006-12-05
申请号：US10638009
申请日：2003-08-08
申请人： Elizabeth M. Doherty , Jiawang Zhu , Markian Stec , Mark H. Norman , Hui-Ling Wang , Christopher H. Fotsch , Ning Chen , Partha P. Chakrabarti , Celia Dominguez , James Richard Falsey , Christopher Hulme , Jodie Katon , Thomas Nixey , Vassil I. Ognyanov , Liping H. Pettus , Robert Michael Rzasa
发明人： Elizabeth M. Doherty , Jiawang Zhu , Markian Stec , Mark H. Norman , Hui-Ling Wang , Christopher H. Fotsch , Ning Chen , Partha P. Chakrabarti , Celia Dominguez , James Richard Falsey , Christopher Hulme , Jodie Katon , Thomas Nixey , Vassil I. Ognyanov , Liping H. Pettus , Robert Michael Rzasa
IPC分类号： C07D239/34 , C07D239/38 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , A61K31/505 , A61K31/506 , A61K31/4427 , A61P19/02 , A61P25/06
CPC分类号： C07D231/40 , C07D209/08 , C07D209/12 , C07D209/42 , C07D209/48 , C07D213/26 , C07D213/643 , C07D213/74 , C07D213/75 , C07D215/227 , C07D215/38 , C07D217/04 , C07D231/56 , C07D233/38 , C07D239/42 , C07D239/90 , C07D241/42 , C07D263/56 , C07D265/36 , C07D277/62 , C07D277/82 , C07D307/79 , C07D319/20 , C07D401/12 , C07D403/12 , C07D405/12 , C07D407/12 , C07D409/14 , C07D413/12 , C07D417/12
摘要： Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
-
-
-
-
-
-
-
-
-
搜索结果
34 条记录 (耗时 0.074 秒)
